Positive high-level results from the TROPION-Lung01 Phase III trial showed datopotamab deruxtecan (Dato-DXd) demonstrated a statistically significant improvement for the dual primary endpoint of...
Belden, a leading global supplier of network infrastructure and digitization solutions, is pleased to announce that the Hirschmann OpEdge-8D is now qualified for AWS...
